RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.
241 results for "psychedelic ethics" — page 1 of 13
ZE_3_06 — Ethics of Psychedelic Research and Therapy
The ethics of psychedelic research and therapy addresses the unique moral challenges posed by substances that profoundly alter consciousness in therapeutic, religious, and research contexts. After a 40-year research mora
ZE_3_18 — Frontier Ethics Survey
Frontier ethics examines the moral dimensions of technologies and practices at the edge of current scientific capability — where regulatory frameworks, ethical traditions, and public understanding lag behind technologica
U_5_13 — Documentary Film and Photography: Witness, Evidence, and Ethics
Documentary film and photography — creative works purporting to represent reality directly, serving as witness, evidence, and social commentary — occupy a uniquely charged position between art and journalism, truth and c
X_2_03 — Psychedelic Medicine: Clinical Evidence and Renaissance
The psychedelic renaissance — the resurgence of clinical research into psychedelic compounds after decades of prohibition — represents one of the most significant paradigm shifts in modern psychiatry. Psilocybin for trea
X_5_13 — Bioethics of Human Experimentation: From Nuremberg to Informed Consent
The bioethics of human experimentation traces the long, often harrowing history of how humans have been used as subjects in medical and scientific research — and the ethical, legal, and institutional frameworks developed
X_4_02 — Medical Ethics: Tuskegee, Helsinki, Informed Consent
The history of medical ethics is inseparable from the history of medical abuse — each major ethical framework emerged in direct response to documented exploitation. The Nuremberg Code (1947) establishing voluntary inform
X_4_11 — Bioethics of Enhancement
The bioethics of enhancement addresses the moral, social, and philosophical questions raised by using medical and technological interventions not merely to treat disease or restore function, but to augment normal human c
K_3_17 — Psychedelic Consciousness — DMT, Psilocybin Neural Effects
The psychedelic renaissance in neuroscience — a period of renewed scientific investigation beginning circa 2006 after decades of regulatory restriction — has produced an unprecedented body of neuroimaging, pharmacologica
INTERDOC_20 — Psychedelic Neuroscience and Ancient Ritual Practice
[KEY FINDING] The Johns Hopkins Center for Psychedelic and Consciousness Research, the Imperial College Centre for Psychedelic Research (est. 2019, directed by Robin Carhart-Harris), and the MAPS (Multidisciplinary Assoc
ZD_2_06 — Ethics of AI and Algorithmic Bias
AI ethics examines the moral implications of designing, deploying, and governing artificial intelligence systems, while algorithmic bias refers to systematic errors in automated decision-making that produce unfair outcom
L_4_12 — CRISPR Gene Drives and Population Genetics Ethics
CRISPR gene drives — genetic engineering systems that combine CRISPR-Cas9 gene editing with super-Mendelian inheritance to spread a modified gene through an entire wild population far faster than natural selection — repr
Y_1_04 — Psychedelic Renaissance — Clinical Research and Consciousness
The psychedelic renaissance — a resurgence of rigorous scientific research on psychedelic substances after decades of prohibition — has produced some of the most significant findings in 21st-century psychiatry and consci
Y_1_06 — Psychedelic Research — Modern Science and Ancient Entheogen Parallels
Psychedelic research has undergone a dramatic revival since ~2006, with major studies at Johns Hopkins, Imperial College London, NYU, and MAPS demonstrating the therapeutic potential of psilocybin, MDMA, and ayahuasca/DM
Y_1_15 — Micro-Dosing: Sub-Perceptual Psychedelic Use and Cognitive Effects
Micro-dosing — the practice of regularly consuming sub-perceptual doses (typically 1/10th to 1/20th of a standard recreational dose) of psychedelic substances, most commonly LSD (~10–20 micrograms) or psilocybin (~0.1–0.
Y_1_07 — Ego Dissolution and Psychedelic Neuroscience
Ego dissolution — the temporary loss of the subjective sense of self, personal boundaries, and the distinction between self and world — is among the most profound and therapeutically significant effects of serotonergic p
Y_1_16 — Psychedelic Legal Frameworks: Regulation, Decriminalization, and Therapeutic Access
The legal status of psychedelic substances — including psilocybin, LSD, MDMA, DMT/ayahuasca, mescaline, and ibogaine — has undergone dramatic shifts since the mid-20th century, moving from unregulated research compounds
Y_1_01 — Altered States, Psychedelics & Ancient Knowledge
Psychoactive substances played a significant — possibly central — role in ancient knowledge traditions. The Eleusinian Mysteries (kykeon), Vedic tradition (Soma), Egyptian practice (blue lotus), and Mesoamerican religion
H_3_10 — Museum Ethics — Who Owns the Past?
The question of who owns the past — and specifically, who has rightful custody of archaeological objects, cultural artifacts, and human remains — is the central ethical controversy in contemporary museum practice. The de
H_4_06 — Suppression of Psychedelic Research (1960s–2000s)
From the late 1940s through the mid-1960s, psychedelic substances — particularly LSD (lysergic acid diethylamide) and psilocybin — were the subject of extensive legitimate scientific research, with over 1,000 peer-review
P_1_15 — Philosophy of Information: Floridi, Digital Ethics, and the Infosphere
The philosophy of information (PI) is a relatively young branch of philosophy that investigates the conceptual nature and basic principles of information, including its dynamics (computation, information flow), its utili
BROWSE BY SECTION — 3,721 documents across 34 fields